You’ve binged enough medical dramas. Now star in a real‑life breakthrough.

Help us research an investigational next gen COVID vaccine.

We’re conducting a research study to assess whether an investigational COVID-19 is safe and induces an immune response. It is hoped that this study will lead to a needle-free and improved option for COVID-19 boosters.

Participants will receive one dose of an investigational vaccine either as a nasal spray or as an inhaled mist. During the study you will have physical exams, blood draws, saliva collection, and nose swabs. You may be compensated up to $1,300 if you complete all study visits. The study will last about seven months.

You could be eligible to take part in a Next Gen COVID Vaccine Study for healthy volunteers aged 18 - 64 years old.

Learn More:
Call: 410-706-8800 (8 am – 4 pm)
Email: clintrial@som.umaryland.edu
Or complete our contact form. 

Study Title: A Phase 1 Open-Label Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike, A Next-Generation SARS-CoV-2 Booster Vaccine Via Intranasal and Inhalational Routes, in Previously Vaccinated Adults (DMID 24-1102)

Study Number: HP-00118353

Principal Investigator: Karen Kotloff, MD